Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001308313 | SCV001497756 | uncertain significance | not provided | 2020-10-25 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamine with arginine at codon 1256 of the IKBKAP protein (p.Gln1256Arg). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and arginine. This variant is present in population databases (rs766517046, ExAC 0.001%). This variant has not been reported in the literature in individuals with a IKBKAP-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: Tolerated; PolyPhen-2: Probably Damaging; Align-GVGD: Class C0). In summary, this variant has uncertain impact on IKBKAP function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002483349 | SCV002784391 | uncertain significance | Medulloblastoma; Familial dysautonomia | 2022-05-28 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000553861 | SCV001452814 | uncertain significance | Familial dysautonomia | 2020-09-16 | no assertion criteria provided | clinical testing |